Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

Aug 28, 2014

Developing New Therapies to Address the Reemergence of Bubonic Plague

As the Black Death again rears its ugly head, researchers seek out a new vaccine and novel drugs to fight it.

Developing New Therapies to Address the Reemergence of Bubonic Plague

3D representation of Yersinia pestis, the bacterium that causes bubonic plague. [Michael Taylor/Shutterstock]

  • Plague arrived in Europe like the opening of a Clive Cussler novel, on a ship of death carrying corpses of individuals felled by some ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »